Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer

  1. Loibl, S.
  2. Loirat, D.
  3. Tolaney, S.M.
  4. Punie, K.
  5. Oliveira, M.
  6. Rugo, H.S.
  7. Bardia, A.
  8. Hurvitz, S.A.
  9. Brufsky, A.M.
  10. Kalinsky, K.
  11. Cortés, J.
  12. O'Shaughnessy, J.A.
  13. Dieras, V.
  14. Carey, L.A.
  15. Gianni, L.
  16. Gharaibeh, M.
  17. Preger, L.
  18. Phan, S.
  19. Chang, L.
  20. Shi, L.
  21. Piccart, M.J.
Revue:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Année de publication: 2023

Volumen: 178

Pages: 23-33

Type: Article

DOI: 10.1016/J.EJCA.2022.10.003 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus